Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Gwenyth A, Fischer"'
Autor:
Andrew G. Wu, Sreyleak Luch, Tina M. Slusher, Gwenyth A. Fischer, Scott A. Lunos, Ashley R. Bjorklund
Publikováno v:
Frontiers in Pediatrics, Vol 12 (2024)
BackgroundBubble continuous positive airway pressure (bCPAP) is used in resource-limited settings for children with respiratory distress. Low-cost modifications of bCPAP use 100% oxygen and may cause morbidity from oxygen toxicity. We sought to test
Externí odkaz:
https://doaj.org/article/a4e4858b36014bfe8ed3bdc1fd668e97
Autor:
Andrew G, Wu, Sreyleak, Luch, Jared R, Floersch, Adam, Keester, Tina M, Slusher, Gwenyth A, Fischer, Joseph E, Hale, Ashley R, Bjorklund
Publikováno v:
The American Journal of Tropical Medicine and Hygiene. 107:724-727
Bubble CPAP is used in low-resource settings to support children with pneumonia. Low-cost modifications of bubble CPAP using 100% oxygen introduces the risk of hyperoxia. Our team developed a low-cost, readily constructible oxygen blender to lower th
Autor:
Andrew Geli Wu, Julia R. Klein, Stephen C. John, Tina M. Slusher, Gwenyth A. Fischer, Ann M. Brearley, Ashley R. Bjorklund
Publikováno v:
The American Journal of Tropical Medicine and Hygiene.
Lower respiratory tract infections (LRTIs) are the leading cause of death in young children globally. Most of the global burden of mortality from LRTIs occurs in low-resource settings (LRSs), where obtaining and maintaining respiratory support device
Autor:
Catherine S, Heith, Lizbeth A, Hansen, Rhonda M, Bakken, Sharon L, Ritter, Breeanna R, Long, Janet R, Hume, Lei, Zhang, Danielle B, Amundsen, Marie E, Steiner, Gwenyth A, Fischer
Publikováno v:
The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 24(4)
OBJECTIVES: With the expanding use of extracorporeal membrane oxygenation (ECMO), understanding drug pharmacokinetics has become increasingly important, particularly in pediatric patients. This ex vivo study examines the effect of a pediatric Quadrox
Publikováno v:
Surgery for Obesity and Related Diseases. 1:262-263